How Generative AI Could Change Pharmaceutical Manufacturing

20 June, 2024
Paul Hanson
Head of Lifecycle Management, Innovation, and Strategy
Takeda Pharmaceuticals

Paul Hanson, Takeda Pharmaceuticals and an active member of ISPE, connected with Bioprocess Online to provide a recap of his session, “How Generative AI is Impacting Pharmaceutical Manufacturing,” presented at the 2024 ISPE Europe Annual Conference.

In the article, Paul shares a helpful example of generative AI usage, provides mitigating strategies to avoid several key risks, discusses how quality by design methodologies fit into the AI discussion, and prescribes a few small steps biotech companies can take to introduce AI into their processes.

Read the full article

About Bioprocess Online

Bioprocess Online is part of the Life Science Connect media group. The publication provides technical information, industry knowledge, and content for the biotherapeutic community. Audiences include bioprocess engineers, scientists, bioprocessing managers, biotechnology producers, consultants, QA/QC, project managers, directors, purchasers, marketers, and those involved in biopharm supply chain or facilities management.